FindTrial
Sign In

LNG-IUD (Progestin)

DEVICE2 trials

Sponsors

Washington University School of Medicine, The Methodist Hospital Research Institute

Conditions

Endometrial Atypical HyperplasiaEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial NeoplasiaEndometrial CancerEndometrial Cancer Stage IEndometrial HyperplasiaFertility-Sparing Treatment (FST)Obesity & Overweight

Phase 2

Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia
WithdrawnNCT05829460
Washington University School of MedicineEndometrial Hyperplasia
Start: 2025-03-12End: 2032-04-30Updated: 2026-01-12
Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
Not yet recruitingNCT07820358
The Methodist Hospital Research InstituteEndometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial Cancer +3
Start: 2027-01-01End: 2031-12-31Target: 48Updated: 2026-09-15